Condensed Consolidated Statements of Operations (Unaudited) (USD $) In Millions, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Net sales	$ 1,874	$ 1,916	$ 5,774	$ 5,804
Cost of products sold	680	623	1,999	1,939
Gross profit	1,194	1,293	3,775	3,865
Operating expenses:
Selling, general and administrative expenses	629	634	1,866	1,897
Research and development expenses	229	230	665	714
Royalty expense	36	39	140	147
Amortization expense	97	129	325	381
Goodwill impairment charges			697	1,817
Intangible asset impairment charges	9	5	21	65
Contingent consideration expense	6		18
Acquisition-related milestone				(250)
Restructuring charges	22	5	77	98
Gain on divestiture	(8)		(768)
Operating expenses	1,020	1,042	3,041	4,869
Operating income (loss)	174	251	734	(1,004)
Other income (expense):
Interest expense	(62)	(91)	(210)	(286)
Other, net	(1)	3	18	(2)
Income (loss) before income taxes	111	163	542	(1,292)
Income tax (benefit) expense	(31)	(27)	208	9
Net income (loss)	$ 142	$ 190	$ 334	$ (1,301)
Net income (loss) per common share - basic	$ 0.09	$ 0.13	$ 0.22	$ (0.86)
Net income (loss) per common share - assuming dilution	$ 0.09	$ 0.12	$ 0.22	$ (0.86)
Weighted-average shares outstanding
Basic	1,514.4	1,519.8	1,523.1	1,517.0
Assuming dilution	1,524.0	1,529.3	1,532.0	1,517.0